Work

Psychosocial care for children receiving chimeric antigen receptor (CAR) T‐cell therapy

Year: 2020

Type: article

Abstract: Chimeric antigen receptor (CAR) T-cell therapy has transformed the treatment of relapsed/refractory B-cell acute lymphoblastic leukemia (ALL). However, this new paradigm has introduced unique considerations specific to the patients receiving CAR T-cell therapy, including prognostic uncertainty, symptom management, and psychosocial support. With increasing availability, there is a growing need for evidence-based recommendations that address the specific psychosocial needs of the children who receive CAR T-cell therapy and their families. To guide and standardize the psychosocial care offered for patients receiving CAR T-cell therapy, we propose the following recommendations for addressing psychosocial support.

Source: Pediatric Blood & Cancer

DOI: 10.1002/pbc.28249

Authors: Angela Steineck, Lori Wiener, Jennifer W. Mack, Nirali N. Shah, Corinne Summers, Abby R. Rosenberg